Catalent Pharma Solutions and Valerius Biopharma AG, will collaborate on the development and manufacture of Valerius’ biosimilar products. Catalent Biologics will provide cell line development and support cGMP manufacturing activities from Phase I through to commercial stages at its state-of-the-art biologics manufacturing facility in Madison, WI. The project will utilize Catalent’s proprietary GPEx technology, which creates high-performance, highly stable production cell lines...